CNTA vs. ARCT

Last updated Aug 1, 2026

CNTA (Centessa Pharmaceuticals Limited) and ARCT (Arcturus Therapeutics Holdings Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Their 0.25 correlation means their historical movements had little consistent relationship.

Performance

CNTA vs. ARCT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Centessa Pharmaceuticals Limited (CNTA) and Arcturus Therapeutics Holdings Inc. (ARCT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNTA

• 1D: —
• 1M: —
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: —

ARCT

• 1D: -2.70%
• 1M: -20.88%
• 6M: -22.89%
• YTD: -6.04%
• 1Y: -53.17%
• 3Y*: -45.16%
• 5Y*: -28.72%
• 10Y*: —
• ALL TIME*: -16.73%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ARCT Arcturus Therapeutics Holdings Inc.	$2.42M	$3.57M	$3.41M

CNTA vs. ARCT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CNTA Centessa Pharmaceuticals Limited	61.94%	49.31%	110.43%	156.77%	-72.47%	-44.40%
ARCT Arcturus Therapeutics Holdings Inc.	-6.04%	-63.88%	-46.18%	85.91%	-54.17%	26.88%

Correlation

The correlation between CNTA and ARCT is 0.11, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.11
Correlation (3Y) Balances recent behavior with more history.	0.26
Correlation (5Y) Shows whether the relationship held over a longer period.	0.25
Correlation (All Time) Calculated using the full available price history since May 28, 2021	0.25

The correlation between CNTA and ARCT shifts across timeframes, from 0.11 (1 year) to 0.26 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS CNTA : -$1.81 ARCT : -$1.80
PS Ratio CNTA : 362.24 ARCT : 3.40
Total Revenue (TTM) CNTA : $15.00M ARCT : $46.80M
Gross Profit (TTM) CNTA : $15.00M ARCT : $40.72M
EBITDA (TTM) CNTA : -$227.27M ARCT : -$84.61M

Return for Risk

CNTA vs. ARCT — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CNTA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

ARCT

ARCT Risk / Return Rank: 21
ARCT Sharpe Ratio Rank: 18
ARCT Sortino Ratio Rank: 23
ARCT Omega Ratio Rank: 22
ARCT Calmar Ratio Rank: 18
ARCT Martin Ratio Rank: 26

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CNTA vs. ARCT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Centessa Pharmaceuticals Limited (CNTA) and Arcturus Therapeutics Holdings Inc. (ARCT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CNTA	ARCT	Difference
Sharpe ratio: Return per unit of total volatility	—	-0.58	—
Sortino ratio: Return per unit of downside risk	—	-0.43	—
Omega ratio: Gain probability vs. loss probability	—	0.94	—
Calmar ratio: Return relative to maximum drawdown	—	-0.70	—
Martin ratio: Return relative to average drawdown	—	-0.89	—

Drawdowns

Drawdown Indicators

	CNTA	ARCT	Difference
Max Drawdown Largest peak-to-trough decline	—	-95.53%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-76.12%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-87.54%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-90.51%	—
Current Drawdown Current decline from peak	—	-95.34%	—
Average Drawdown Average peak-to-trough decline	—	-73.48%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	59.69%	—

Volatility

Volatility by Period

	CNTA	ARCT	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	13.40%	—
Volatility (6M) Calculated over the trailing 6-month period	—	39.07%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	90.94%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	91.54%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	101.26%	—

Dividends

CNTA vs. ARCT - Dividend Comparison

Neither CNTA nor ARCT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CNTA and ARCT in my portfolio?

CNTA and ARCT have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.